Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

08 October 2025: Clinical Research  

Immersive Virtual Reality Therapy for Elderly Female Patients Undergoing Rehabilitation After Hip Arthroplasty: A Randomized Controlled Pilot Trial

Joanna Szczepańska-Gieracha ORCID logo ADEFG 1, Adam Wrzeciono ORCID logo CEF 1, Błażej Cieślik ORCID logo ACE 2*, Robert Gajda ORCID logo DEF 3,4, Justyna Mazurek ORCID logo ABDEF 5

DOI: 10.12659/MSM.948321

Med Sci Monit 2025; 31:e948321

0 Comments

Abstract

0:00

BACKGROUND: Osteoarthritis often leads to total hip arthroplasty (THA), and effective postoperative rehabilitation is critical to recovery. This study tested whether adding virtual reality (VR) to standard inpatient rehabilitation improves psychological well-being and functional performance in women after THA.

MATERIAL AND METHODS: This pilot randomized controlled trial was conducted with 24 female patients aged 60 and older. Participants were randomized into two groups: a control group receiving 4-week standard rehabilitation and an experimental group receiving standard rehabilitation plus VR therapy. Psychological and functional statuses were assessed using the Hospital Anxiety and Depression Scale (HADS), Perception of Stress Questionnaire (PSQ), and various functional tests before and after the intervention.

RESULTS: The experimental group showed significant improvements in psychological outcomes, with a 53% reduction in overall HADS scores and a 43% reduction in PSQ scores. Functional improvements were also observed, with significant increases in Tinetti Test, Barthel Index, and Rivermead Motor Assessment scores. In contrast, the control group showed no significant changes in psychological parameters and less pronounced functional improvements.

CONCLUSIONS: Adjunctive VR during post-THA rehabilitation improved psychological well-being and functional performance in women aged 65 years and older compared with usual care, and improvements in these domains were positively correlated. These preliminary results support VR as a promising adjunct to target both psychological and functional recovery, but confirmation in larger, multicenter trials with longer follow-up and economic evaluation is required.

Keywords: Arthroplasty, Replacement, Hip, Depression, Rehabilitation, Relaxation Therapy, virtual reality, Virtual Reality Exposure Therapy, Humans, Female, Pilot Projects, Aged, Middle Aged, Treatment Outcome, Surveys and Questionnaires, Anxiety

Introduction

The demand for total hip arthroplasty (THA) is rising. Across OECD countries, hip replacement rates averaged about 172 per 100,000 population in 2021 and are expected to grow further with population ageing [1]. In 2022, a total of 64,694 hip replacement surgeries were performed across Poland under agreements with the Polish National Health Fund (NFZ). According to NFZ data, the leading indications for primary THA were primary coxarthrosis, femoral neck fracture, and other primary coxarthroses, while mechanical complications of internal joint prostheses were the most common indication for revision surgery [2]. These national trends mirror international patterns of increasing procedure volume and underscore the need to optimize post-THA recovery pathways [1].

Osteoarthritis (OA), the most common form of arthritis worldwide [3], is characterized by cartilage degeneration, osteophyte formation, subchondral sclerosis, and weakening of periarticular muscles [4]. In 2020, an estimated 595 million people were living with OA, roughly 7.6% of the global population, with hip OA cases projected to increase by about 79% by 2050 [3]. These pathological changes result in pain, functional limitations, and disability, placing a substantial burden on individuals and society. Typical symptoms include joint pain, stiffness, and reduced range of motion, and multiple joints can be affected, particularly the hips, knees, hands, feet, and spine [5].

Persistent pain is the hallmark of OA and a major contributor to healthcare use, functional limitation, and reduced quality of life. Lower-extremity OA is a leading cause of mobility impairment in older adults [6] and contributes substantially to years lived with disability worldwide [3]. Pain persisting beyond 6 months, especially in the presence of comorbid mental health conditions or multisite pain, is associated with poorer psychological well-being and overall health status. This highlights the need to evaluate the psychological well-being in people living with persistent pain and chronic conditions and to develop clinical strategies that support both domains [7]. Notably, preoperative psychological distress, including anxiety and depression, is linked to worse postoperative pain and function and a higher complication risk after THA, which supports integrating psychological assessment and support into rehabilitation [8]. Despite this evidence, psychological evaluation and intervention are not yet standard practice in orthopedic rehabilitation in Europe.

Standard care for adults who have undergone THA for end-stage OA includes postoperative rehabilitation to optimize function, reduce pain, and restore activities of daily living. Although no disease-modifying treatments currently exist for OA, rehabilitation, particularly structured exercise therapy, remains a cornerstone of symptom management, with evidence for benefits in pain, physical function, and quality of life. Advances in protocols, including individualized exercise, weight management, and digital health supports, can further improve outcomes. An expert consensus recommends therapeutic exercise for 4 to 8 weeks, 3 to 5 sessions per week, following THA [9]. Programs typically include resistance exercises and gait training and can be delivered at different postoperative stages, intensities, and settings, tailored to individual, social, and financial circumstances. However, uncertainty remains regarding which specific components should be standardized to maximize clinical outcomes and reduce avoidable complications or implant failure [10].

After THA, physiotherapy commonly includes cryotherapy, passive and active mobilizations initiated soon after surgery, and exercises aimed at improving hip function and strength [11]. Traditional approaches that rely heavily on passive and analytical exercises can be perceived as monotonous and insufficiently engaging, which can undermine motivation and adherence. Moreover, high socio-economic costs can limit continuity of care [12].

Virtual reality (VR) provides an immersive, multimodal simulated environment that can increase engagement and the sense of presence during therapy [13]. Use of VR-based rehabilitation in orthopedics, including THA and total knee arthroplasty, has expanded in recent years [14], and multiple VR-based postoperative protocols have been proposed [15]. Randomized trials indicate that, after THA, VR-based rehabilitation is comparable or superior to conventional therapy for early functional recovery, and after total knee arthroplasty it reduces early postoperative pain and anxiety, with mixed longer-term effects [16,17]. Nevertheless, evidence on VR’s effectiveness for alleviating stress, anxiety, or depressive symptoms after THA or total knee arthroplasty remains limited. Therefore, the primary aim of the present study was to determine the impact of VR therapy on the psychological and functional state of patients participating in rehabilitation after total hip arthroplasty. We hypothesize that VR therapy significantly enhances both the psychological and functional states of patients, with a positive correlation between improvements in these 2 parameters.

Material and Methods

STUDY DESIGN, SETTING, AND PARTICIPANTS:

This study was designed as a single-blinded, randomized pilot clinical trial with blinded outcome assessors and was conducted at St. Hedwig Hospital in Trzebnica, Poland. Due to the nature of the intervention involving VR therapy, it was not possible to blind the patients or the intervention providers. In accordance with participant recruitment guidelines for pilot randomized trials outlined by Julious (2005) and Whitehead et al (2015) [18,19], we consecutively enrolled 24 female patients between March and August 2023. The main inclusion criteria were female sex, age of 60 years or older, and having undergone THA. The primary exclusion criteria were contraindications to using VR therapy (eg, dizziness, epilepsy, significant visual impairments), inability to independently complete questionnaires, and refusal to participate in the study.

Participants were allocated into 2 groups by block randomization with computer-generated permuted blocks of size 4 at Randomizer.org, without stratification. Allocation concealment was ensured with sequentially numbered, opaque, and sealed envelopes prepared off-site. Outcome assessors remained blinded throughout data collection through separation of roles, no access to the randomization list, allocation records, or envelopes, and scheduling that prevented contact with treating therapists. To minimize bias, the intervention providers were not involved in the assessment process. Specifically, the individuals administering the intervention did not participate in evaluating its outcomes, ensuring an independent assessment by blinded evaluators

The study protocol was approved by the Bioethics Committee at the Wrocław Medical University, Poland (119/KB/2023), and registered in the ClinicalTrials.gov database (NCT06506760). All participants provided written informed consent prior to any study procedures.

INTERVENTIONS:

Patients from both groups participated in a standard rehabilitation program following THA, lasting 4 weeks as an inpatient regimen. The program included kinesitherapy, with 2-h daily gait training sessions, occupational therapy for 30 min each day, and physiotherapy treatments, such as laser therapy, cryotherapy, magnetic field therapy, and electrotherapy, which were individually tailored to meet each patient’s specific needs.

Additionally, patients in the experimental group participated in 8 VR therapy sessions (2 times per week), supplementing the standard rehabilitation. Each VR session lasted up to 20 min. The VR therapy was conducted using the VRTierOne medical device by Stolgraf (Stanowice, Poland). This device was equipped with HTC VIVE VR goggles and an HTC VIVE controller that tracked the movements of the dominant wrist. The use of VRTierOne was aimed to transport patients into a calm, virtual world, enabling relaxation and helping to soothe emotions. Each therapeutic session began at a gate through which patients entered a garden. With each session, the garden dynamically developed, becoming increasingly vibrant. In the middle of each therapeutic session, a mandala appeared in the garden, which the patients were tasked with coloring. The VR therapy was based on the principles of Ericksonian psychotherapy, making use of metaphors, hypnosis, and symbolism. Additionally, the background of the VR therapy consisted of relaxation music, which changed as the therapy progressed. A detailed description of the VR therapy principles has been described in previous works [13,20,21]. Adverse events were monitored at each session by the treating therapist using a standardized checklist, and their onset, severity, and relatedness to the intervention were recorded in the case report forms.

Participants and intervention providers were aware of group assignments. Protocol adherence was ensured via automatic VR system logs and post-session therapist fidelity checklists, which were audited weekly against predefined deviation criteria by a supervising investigator. No protocol deviations were recorded.

OUTCOME MEASURES:

Participants completed a custom questionnaire to collect basic sociodemographic data, including age, weight, height, body mass index (BMI), education level, and marital status. The study assessed both psychological and functional status through evaluations conducted at 2 time points: prior to the intervention (week 0) and upon its completion (week 4).

The primary outcome measure was the Polish version of the Hospital Anxiety and Depression Scale (HADS), which detects depressive and anxiety states [22]. It consists of 14 questions, with 7 each related to anxiety and depression. Higher scores on the HADS indicate higher levels of anxiety and/or depression, with cut-off scores of 8 and above on each subscale suggesting elevated anxiety or depression, and scores above 10 indicating a pathological state.

Secondary outcome measures included assessments of psychological status using the Polish versions of the Perception of Stress Questionnaire (PSQ), Generalized Self-Efficacy Scale (GSES), and visual analog scale (VAS) for pain. The PSQ measures generalized stress levels through 3 components: emotional tension, external stress, and intrapsychic stress, with overall scores ranging from 21 to 105 points [23]. A subscale cut-off score of 20 points suggests a borderline average result, with higher scores indicating greater tension or stress. The GSES assesses the general sense of self-efficacy, evaluating whether patients can anticipate coping strategies for daily problems and adapt to stressful situations [24]. Scores below 25 suggest low self-efficacy, while scores above 30 indicate high self-efficacy. The VAS for pain assessment ranges from 0 to 10, where 0 indicates no pain and 10 indicates the greatest possible pain [25].

Functional evaluations included the Tinetti test, Barthel Index of Activities of Daily Living, Rivermead Motor Assessment Gross Function Subscale (RMA-GF), and Short Physical Performance Battery (SPPB). The Tinetti Short Scale, a simplified version of the Tinetti Performance-Oriented Mobility Assessment, evaluates a patient’s gait and balance through tasks such as sitting to standing, standing still for 5 s, walking 3 m, turning 180 degrees, and maintaining a sitting position [26]. Each task is rated on a 3-point Likert scale, with total scores ranging from 0 to 15, where higher scores indicate better functional mobility. The Barthel Index analyzes patients’ ability to perform daily living activities, awarding points on a scale from 0 to 10 for each activity, with a maximum score of 100 points [27]. Higher scores indicate better functional status, while lower scores indicate greater limitations in daily activities. The RMA-GF was used to assess patient mobility, modified to exclude the 10-m run and jumping tasks, due to THA contraindications [28]. The test included 11 tasks, with each correctly performed task earning 1 point, ranging from sitting independently to walking 40 m and climbing stairs. Higher scores, up to a maximum of 11, indicated greater functional capabilities and lower disability. The SPPB assesses the physical fitness of older adults and consists of 3 different types of physical activities: balance maintenance, gait speed, and chair rising [29]. A maximum score of 12 points can be achieved, and a low score can suggest potential mobility issues in the near future, possibly leading to the need for hospitalization or long-term care.

DATA ANALYSIS:

Statistical analysis was conducted using JASP software, version 0.18.3 (University of Amsterdam, Netherlands). Descriptive data for categorical variables are presented as frequencies and percentages. For continuous variables, the mean and standard deviation (SD) were calculated. Group characteristics were compared using the chi-square test and the unpaired t test. The Shapiro-Wilk test was used to confirm that the distribution of the obtained results was close to normal. The effects of the intervention between groups were evaluated using analysis of variance (ANOVA) supplemented by unpaired t tests for independent groups (between-group effects) and dependent groups (within-group effects). Eta squared (*eegr;2) values were interpreted based on Cohen’s guidelines, with 0.01 indicating a small effect, 0.06 a medium effect, and 0.14 or greater indicating a large effect. Effect sizes for t tests were assessed using Cohen’s d, with absolute values reported. A Cohen’s d of 0.2 indicates a small effect, 0.5 indicates a medium effect, and 0.8 or greater indicates a large effect [30]. The relationship between changes in psychological and functional parameters was examined using Spearman’s rank correlation coefficient. Values of P<0.05 were considered statistically significant.

Results

PARTICIPANT CHARACTERISTICS:

As illustrated in Figure 1, following an initial eligibility assessment, 24 women were randomly allocated to 1 of 2 treatment groups. One patient from the experimental group did not finish the intervention due to eyesight problems in VR.

The average age of patients in the experimental group was 71.91 years, which was 0.26 years lower than that in the control group (Table 1). The average height in the experimental group was 0.35 cm higher than in the control group (experimental 161.27 cm and control 160.92 cm). The average weight of patients in the VR therapy group was 0.65 kg lower (experimental 74.18 kg and control 74.83 kg), and the average BMI was 0.38 lower than in the control group (experimental 28.69 kg/m2 and control 29.07 kg/m2). Among all patients, 5 had a normal BMI, 10 had overweight, and 8 had obesity. Regarding education, 11 patients had vocational education, 9 had secondary education, and 3 had higher education. In terms of marital status, 15 patients were married, 7 were widows, and 1 was divorced. There were no statistically significant differences between the groups in the various variables.

PSYCHOLOGICAL STATE:

As shown in Table 2, in the context of psychological state, statistically significant changes with medium to large effect size were observed in all measured parameters between measurement points in the experimental group, except for HADS-D (P=0.16). The overall HADS score significantly decreased by 53% (from 12.55 to 5.91; P=0.03, d=0.79), while the anxiety component (HADS-A) significantly decreased by 58% (from 7.00 to 2.91; P=0.01, d=0.92). The overall PSQ score significantly decreased by 43% (from 64.82 to 37.00; P<0.001, d=1.70). Analysis of the individual stress components measured by the PSQ showed significant decreases: a 52% reduction in emotional tension (from 24.18 to 11.55; P<0.001, d=1.58), a 31% reduction in external stress (from 19.73 to 13.55; P=0.01, d=0.99), and a 43% reduction in intrapsychic stress (from 20.91 to 11.91; P<0.01, d=2.10). The GSES questionnaire results indicated a significant increase in self-efficacy after the intervention by 45% (from 26.73 to 38.82; P<0.001, d=1.81). The analysis of the VAS scale results showed a significant reduction in pain experienced by patients by 84% (from 4.55 to 0.73; P<0.001, d=1.68).

In contrast to the experimental group, the control group showed no significant changes between measurements in psychological state variables (P>0.05), except for the VAS scale, which showed a small but significant improvement (P=0.02, d=0.25). Additionally, significant differences in intervention efficacy with large effect size (d>0.8) were observed between the groups in all measured psychological parameters, except for HADS-D (P=0.12, d=0.69, Table 2), favoring the intervention used in the experimental group. Furthermore, the ANOVA results indicating significant group-by-time interactions with a large effect size (η2 P>0.14; Table 3) confirmed the observed differences in the effectiveness of interventions between the groups in terms of psychological parameters.

FUNCTIONAL STATE:

Statistical changes with large effect size (d>0.8) were observed in all measured parameters between the measurement points in the experimental group (Table 4). After the intervention, the Tinetti test score significantly increased by 200% (from 3.27 to 9.82; P<0.001, d=2.43). The same trend was observed in other functional tests: the Barthel Index score increased by 66.7% (from 55.91 to 93.18; P<0.001, d=2.84), the RMA-GF test score increased by 131.9% (from 4.27 to 9.91; P<0.001, d=2.95), and the SPPB test score increased by 143.2% (from 3.36 to 8.18; P<0.01, d=1.18). Similarly, in the control group, a significant increase with a small effect size (0.2≤ d<0.5) in functional parameter outcomes was observed after the intervention (P<0.001 for Tinetti, Barthel, RMA-GF tests, and P<0.01 for the SPPB test). Additionally, significant differences in intervention efficacy with large effect size (d>0.8) between the groups were observed across all measured functional parameters, except for SPPB (P=0.10, d=0.73, Table 4), favoring the intervention applied in the experimental group.

Furthermore, the results of ANOVA indicating significant interactions between group and measurement point with large effect size (η2P >0.14; Table 3) confirm the observed difference in the efficacy of the interventions applied between the groups in terms of functional parameters.

CORRELATIONS:

Figure 2 shows the correlation between changes in psychological parameters and changes in functional parameters. Significant correlations were observed between the differences in psychological parameters and the following test results: SPPB (ranging from 0.43 to 0.74), Barthel Index (ranging from 0.42 to 0.60), and Tinetti test (ranging from 0.54 to 0.59). For the change in RMA-GF scores, a significant correlation of 0.43 was observed only with the change in GSES scores. All significant correlations were positive, suggesting that larger differences between measurements in psychological parameters correlated with greater differences in functional parameters, and vice versa.

Discussion

CLINICAL IMPLICATIONS:

Adjunctive VR can be used as a targeted addition to post-THA rehabilitation, addressing both the psychological well-being and functional recovery of patients. Its immersive format can enhance motivation and engagement, and therapeutically scripted content can help manage anxiety and depressive symptoms that often hinder participation. In practice, services could introduce brief psychological screening at intake to identify candidates, schedule VR alongside physiotherapy with content mapped to rehabilitation goals, and monitor adherence via system logs, supported by therapist training, fidelity checklists, and standard adverse-event reporting. At the service and policy level, the adoption of VR should be paired with prospective evaluation of feasibility, acceptability, fidelity, cost, and equity, with clear procedures for procurement, data security, and documentation. Economic evaluations and multicenter studies can then inform guideline recommendations, reimbursement pathways, and criteria for integrating VR-based psychological components into routine post-THA care.

LIMITATIONS:

Given the pilot design of the study, several limitations should be considered when interpreting these findings. This study enrolled a small, single-center sample of 24 women, which limits generalizability and yields imprecise effect estimates. The intervention spanned 4 weeks, with no extended follow-up; therefore, the durability of effects cannot be determined. Psychological outcomes were based on self-report scales, introducing potential response and expectancy bias despite assessor blinding. As a pilot study, it was not powered for definitive between-group efficacy conclusions. Future research should include a larger, more diverse, and multicenter cohort, extend follow-up to the medium and long term, incorporate objective and clinician-rated outcomes alongside patient-reported measures, and be prospectively powered. Mediation analyses could test whether psychological change underpins functional gains.

Conclusions

In this randomized pilot study, we evaluated whether adjunctive VR therapy improves psychological well-being and functional status in women aged 65 years and older undergoing post-THA rehabilitation, and whether improvements in these domains are correlated. The VR group showed significant gains across psychological measures and larger improvements in functional tests relative to the control group, and greater psychological improvement was associated with greater functional recovery. These findings suggest that VR can be a useful adjunct to conventional rehabilitation for targeting psychological and functional outcomes. Given the small, single-center sample, short intervention period, and reliance on self-reported psychological measures, the results should be considered preliminary. Confirmation in larger, more diverse multicenter trials with longer follow-up and economic evaluation is needed before recommending routine implementation. Pending such evidence, rehabilitation services can consider exploring VR as a targeted option for patients with elevated psychological distress or low engagement within structured and monitored programs.

References

1. Organisation for Economic Co-operation and Development: Health at a Glance 2023: OECD Indicators, 2023, OECD Publishing

2. Polish National Health Fund, 2022 Available from: [in Polish]https://www.nfz.gov.pl/o-nfz/publikacje/

3. Steinmetz JD, Culbreth GT, Haile LM, Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021: Lancet Rheumatol, 2023; 5(9); e508-e22

4. Yunus MHM, Nordin A, Kamal H, Pathophysiological perspective of osteoarthritis: Med Kaunas Lith, 2020; 56(11); 614

5. Santos MM, Santos AM, Carvalho Nascimento JA, Devices for osteoarthritis symptoms treatment: a patent review: Expert Rev Med Devices, 2024; 21(1–2); 91-107

6. Neogi T, The epidemiology and impact of pain in osteoarthritis: Osteoarthr Cartil OARS Osteoarthr Res Soc, 2013; 21(9); 1145-53

7. Tang LH, Andreasson KH, Thygesen LC, Persistent pain and long-term physical and mental conditions and their association with psychological well-being; Data from 10,744 individuals from the Lolland-Falster health study: J Multimorb Comorbidity, 2022; 12; 26335565221128712

8. O’Connor JP, Holden P, Gagnier JJ, Systematic review: Preoperative psychological factors and total hip arthroplasty outcomes: J Orthop Surg, 2022; 17(1); 457

9. , Expert Consensus on best practices for post-acute rehabilitation after total hip and knee arthroplasty: A Canada and United States Delphi study: Arthritis Care Res, 2014; 66(3); 411-23

10. Konnyu KJ, Pinto D, Cao W, Rehabilitation for total hip arthroplasty: A systematic review: Am J Phys Med Rehabil, 2023; 102(1); 11-18

11. Jenkins C, Lowe CM, Barker KL, Early post-operative physiotherapy rehabilitation after primary unilateral unicompartmental knee replacement: A systematic review: Physiotherapy, 2023; 118; 39-53

12. Fatoye F, Gebrye T, Fatoye C, Mbada C, A systematic review of economic models for cost effectiveness of physiotherapy interventions following total knee and hip replacement: Physiotherapy, 2022; 116; 90-96

13. Szczepańska-Gieracha J, Jóźwik S, Cieślik B, Immersive virtual reality therapy as a support for cardiac rehabilitation: A pilot randomized-controlled trial: Cyberpsychology Behav Soc Netw, 2021; 24(8); 543-49

14. Peng L, Zeng Y, Wu Y, Virtual reality-based rehabilitation in patients following total knee arthroplasty: A systematic review and meta-analysis of randomized controlled trials: Chin Med J (Engl), 2021; 135(2); 153-63

15. García-Sánchez M, García-Robles P, Osuna-Pérez MC, Effectiveness of virtual reality-based early postoperative rehabilitation after total knee arthroplasty: A systematic review with meta-analysis of randomized controlled trials: Appl Sci, 2023; 13(7); 4597

16. Zavala-González J, Martínez D, Gutiérrez-Espinoza H, Effectiveness of adding virtual reality to physiotherapeutic treatment in patients with total hip arthroplasty. A randomized controlled trial: Clin Rehabil, 2022; 36(5); 660-68

17. Fascio E, Vitale JA, Sirtori P, Early Virtual-reality-based home rehabilitation after total hip arthroplasty: A randomized controlled trial: J Clin Med, 2022; 11(7); 1766

18. Julious SA, Sample size of 12 per group rule of thumb for a pilot study: Pharm Stat, 2005; 4(4); 287-91

19. Whitehead AL, Julious SA, Cooper CL, Campbell MJ, Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable: Stat Methods Med Res, 2016; 25(3); 1057-73

20. Jóźwik S, Wrzeciono A, Cieślik B, The use of virtual therapy in cardiac rehabilitation of male patients with coronary heart disease: A randomized pilot study: Healthc Basel Switz, 2022; 10(4); 745

21. Cieślik B, Juszko K, Kiper P, Szczepańska-Gieracha J, Immersive virtual reality as support for the mental health of elderly women: A randomized controlled trial: Virtual Real, 2023; 27; 2227-35

22. Bjelland I, Dahl AA, Haug TT, Neckelmann D, The validity of the Hospital Anxiety and Depression Scale. An updated literature review: J Psychosom Res, 2002; 52(2); 69-77

23. Plopa M, Makarowski R, The perception of stress questionnaire: Manual, 2010, Vizja Press & IT

24. Luszczynska A, Scholz U, Schwarzer R, The general self-efficacy scale: Multicultural validation studies: J Psychol, 2005; 139(5); 439-57

25. Heller GZ, Manuguerra M, Chow R, How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance: Scand J Pain, 2016; 13; 67-75

26. Tinetti ME, Williams TF, Mayewski R, Fall risk index for elderly patients based on number of chronic disabilities: Am J Med, 1986; 80(3); 429-34

27. Mahoney FI, Barthel DW, Functional evaluation: The Barthel Index: Md State Med J, 1965; 14; 61-65

28. Collen FM, Wade DT, Robb GF, Bradshaw CM, The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment: Int Disabil Stud, 1991; 13(2); 50-54

29. Lauretani F, Ticinesi A, Gionti L, Short-Physical Performance Battery (SPPB) score is associated with falls in older outpatients: Aging Clin Exp Res, 2019; 31(10); 1435-42

30. Cohen J: Statistical power analysis for the behavioral sciences, 2013, Routledge

31. Mazurek J, Cieślik B, Wrzeciono A, Gajda R, Szczepańska-Gieracha J, Immersive virtual reality therapy is supportive for orthopedic rehabilitation among the elderly: A randomized controlled trial: J Clin Med, 2023; 12(24); 7681

32. Siddiqui N, Dwyer M, Stankovich J, Hospital length of stay variation and comorbidity of mental illness: A retrospective study of five common chronic medical conditions: BMC Health Serv Res, 2018; 18(1); 498

33. Trivedi MH, The link between depression and physical symptoms: Prim Care Companion J Clin Psychiatry, 2004; 6(Suppl 1); 12-16

34. Brenes GA, Anxiety, depression, and quality of life in primary care patients: Prim Care Companion J Clin Psychiatry, 2007; 9(6); 437-43

35. National Collaborating Centre for Mental Health (UK): Depression in Adults with a Chronic Physical Health Problem: Treatment and Management, 2010, British Psychological Society (UK)

36. Gerdle B, Åkerblom S, Brodda Jansen G, Who benefits from multimodal rehabilitation – an exploration of pain, psychological distress, and life impacts in over 35,000 chronic pain patients identified in the Swedish Quality Registry for Pain Rehabilitation: J Pain Res, 2019; 12; 891-908

37. Ehioghae M, Montoya A, Keshav R, Effectiveness of virtual reality–based rehabilitation interventions in improving postoperative outcomes for orthopedic surgery patients: Curr Pain Headache Rep, 2024; 28(1); 37-45

38. Vincent HK, Horodyski M, Vincent KR, Psychological distress after orthopedic trauma: Prevalence in patients and implications for rehabilitation: PM R, 2015; 7(9); 978-89

39. Crofford LJ, Psychological aspects of chronic musculoskeletal pain: Best Pract Res Clin Rheumatol, 2015; 29(1); 147-55

40. Leo AJ, Schuelke MJ, Hunt DM, A digital mental health intervention in an orthopedic setting for patients with symptoms of depression and/or anxiety: Feasibility prospective cohort study: JMIR Form Res, 2022; 6(2); e34889

41. Le J, Dorstyn D, Anxiety prevalence following spinal cord injury: A meta-analysis: Spinal Cord, 2016; 54(8); 570-78

In Press

Clinical Research  

Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...

Med Sci Monit In Press; DOI: 10.12659/MSM.951027  

Clinical Research  

Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...

Med Sci Monit In Press; DOI: 10.12659/MSM.950516  

Review article  

Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.951283  

Clinical Research  

Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 Adults

Med Sci Monit In Press; DOI: 10.12659/MSM.950938  

Most Viewed Current Articles

17 Jan 2024 : Review article   10,187,196

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

13 Nov 2021 : Clinical Research   3,708,487

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

0:00

14 Dec 2022 : Clinical Research   2,341,643

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   706,524

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750